Manipulation of DNA damage checkpoint signaling in cancer cells by antioxidant biofactor (AOB)

Food and Function

Volumn 4, Issue 1, 2013, Pages 63-73

  Tatewaki, Naoto ^a   Bhilwade, Hari Narayan ^b   Nishida, Hiroshi ^a   Nakajima, Yuki ^a   Konishi, Tetsuya ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

A549 CELLS; ANTICANCER TREATMENT; BENEFICIAL USE; CANCER CELLS; CELL TOXICITY; COMET ASSAYS; DISTILLED WATER; DNA DAMAGES; DNA REPAIR; DOSE-DEPENDENT; DUAL ROLE; FERMENTED GRAINS; FOOD SUPPLEMENTS; HIGH DOSE; INHIBITORY EFFECT; INHIBITORY PROFILES; INITIAL STAGES; LOW DOSE; POLYPHENOLS; REPAIR PROCESS; UV-INDUCED DNA DAMAGE; WATER EXTRACTS;

CELL DEATH; DNA; MOLECULAR BIOLOGY; PHENOLS; PHOSPHORYLATION;

EXTRACTION;

ANTIOXIDANT BIOFACTOR AOB; CELL CYCLE PROTEIN; PHENOL DERIVATIVE; PLANT EXTRACT;

ADENOCARCINOMA; ARTICLE; CELL CYCLE CHECKPOINT; CHEMISTRY; DNA DAMAGE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ADENOCARCINOMA; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHENOLS; PLANT EXTRACTS; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 84871784156     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c2fo30088e     Document Type: Article

References (42)

1. S. R. Maxwell Prospects for the use of antioxidant therapies Drugs 1995 49 345 361
2. H. Nishida N. Tatewaki Y. Nakajima T. Magara K. M. Ko Y. Hamamori T. Konishi Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response Nucleic Acids Res. 2009 37 5678 5689
3. Y. Shiloh ATM and ATR: networking cellular responses to DNA damage Curr. Opin. Genet. Dev. 2001 11 71 77
4. R. T. Abraham Cell cycle checkpoint signaling through the ATM and ATR kinases Genes Dev. 2001 15 2177 2196
5. Y. Shiloh ATM and related protein kinases: safeguarding genome integrity Nat. Rev. Cancer 2003 3 155 168
6. T. Kawabe G2 checkpoint abrogators as anticancer drugs Mol. Cancer Ther. 2004 3 513 519
7. N. Bucher C. D. Britten G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer Br. J. Cancer 2008 98 523 528
8. Y. Minamiyama S. Takemura T. Yoshikawa S. Okada Fermented grain products, production, properties and benefits to health Pathophysiology 2003 9 221 227
9. Y. Minamiyama T. Yoshikawa T. Tanigawa S. Takahashi Y. Naito H. Ichikawa M. Kondo Antioxidative effects of a processed grain food J. Nutr. Sci. Vitaminol. 1994 40 467 477
10. Y. Minamiyama S. Takemura S. Toyokuni Y. Tanimoto E. F. Sato M. Inoue A processed grain food inhibits hepatic injury in endotoxemic rats J. Nutr. Sci. Vitaminol. 1998 44 547 559
11. Y. Minamiyama, E. Sato, S. Takemura, M. Inoue and T. Yoshikawa, Oxidative stress and antioxidant biofactor (AOB), in Food and Free Radicals, ed., M. Hiramatsu, T. Yoshikawa, and, M. Inoue, Plenum Press, New York, 1997, pp. 137-140
12. I. Emerit N. Oganesian R. Arutyunian A. Pogossian T. Sarkisian L. Cernjavski A. Levy J. Feingold Oxidative stress-related clastogenic factors in plasma from Chernobyl liquidators: protective effects of antioxidant plant phenols, vitamins and oligoelements Mutat. Res., Fundam. Mol. Mech. Mutagen. 1997 377 239 246
13. A. Mizote Y. Okazaki M. Iqbal S. Okada Antioxidant biofactor, a processed grain food, inhibits iron nitrilotriacetate-induced renal tumorigenesis, hyperproliferative response, and oxidative damage Hum. Exp. Toxicol. 2008 27 207 214
14. H. Nishida M. Kushida Y. Nakajima Y. Ogawa N. Tatewaki S. Sato T. Konishi Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction J. Pharmacol. Sci. 2007 104 73 81
15. H. N. Bhilwade N. Tatewaki V. V. Giridharan H. Nishida T. Konishi Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice Food Funct. 2010 1 174 179
16. K. Konca A. Lankoff A. Banasik H. Lisowka T. Kuszewski S. Gozdz Z. Koza A. Wojcik Across platform public domain PC image analysis programme for the comet assay Mutat. Res., Genet. Toxicol. Environ. Mutagen. 2003 534 15 20
17. M. J. O'Connell K. A. Cimprich G2 damage checkpoints: what is the turn-on? J. Cell Sci. 2005 118 1 6
18. L. Zou S. J. Elledge Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes Science 2003 300 1542 1548
19. J. M. Wagner S. H. Kaufmann Prospects for the use of ATR inhibitors to treat cancer Pharmaceuticals 2010 3 1311 1334
20. B. B. Zhou J. Bartek Targeting the checkpoint kinases: chemosensitization versus chemoprotection Nat. Rev. Cancer 2004 4 216 225
21. T. Sakai M. Kogiso Soy isoflavones and immunity J. Med. Invest. 2008 55 167 173
22. H. N. Bhilwade N. Tatewaki H. Nishida T. Konishi Squalene as novel food factor Curr. Pharm. Biotechnol. 2010 11 875 880
23. G. C. Yen J. W. Ju C. H. Wu Modulation of tea and tea polyphenols on benzo(a)pyrene-induced DNA damage in Chang liver cells Free Radical Res. 2004 38 193 200
24. H. Celik E. Arinç Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage J. Pharm. Pharm. Sci. 2010 13 231 241
25. K. Kawakami H. Nishida N. Tatewaki Y. Nakajima T. Konishi M. Hirayama Persimmon leaf extract inhibits the ATM activity during DNA damage response induced by Doxorubicin in A549 lung adenocarcinoma cells Biosci., Biotechnol., Biochem. 2011 75 650 655
26. Y. Sanchez C. Wong R. S. Thoma R. Richman Z. Wu H. Piwnica-Worms S. J. Elledge Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25 Science 1997 277 1497 1501
27. C. Y. Peng P. R. Graves R. S. Thoma Z. Wu A. S. Shaw H. Piwnica-Worms Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 Science 1997 277 1501 1505
28. H. Zhao H. Piwnica-Worms ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1 Mol. Cell. Biol. 2001 21 4129 4139
29. M. Raman S. Earnest K. Zhang Y. Zhao M. H. Cobb TAO kinases mediate activation of p38 in response to DNA damage EMBO J. 2007 26 2005 2014
30. I. A. Manke A. Nguyen D. Lim M. Q. Stewart A. E. Elia M. B. Yaffe MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation Mol. Cell 2005 17 37 48
31. J. N. Sarkaria E. C. Busby R. S. Tibbetts P. Roos Y. Taya L. M. Karnitz R. T. Abraham Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine Cancer Res. 1999 59 4375 4382
32. S. J. Collis M. J. Swartz W. G. Nelson T. L. DeWeese Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors Cancer Res. 2003 63 550 554
33. I. Hickson Y. Zhao C. J. Richardson S. J. Green N. M. Martin A. I. Orr P. M. Reaper S. P. Jackson N. J. Curtin G. C. Smith Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM Cancer Res. 2004 64 9152 9159
34. S. E. Golding E. Rosenberg N. Valerie I. Hussaini M. Frigerio X. F. Cockcroft W. Y. Chong M. Hummersone L. Rigoreau K. A. Menear M. J. O'Connor L. F. Povirk T. van Meter K. Valerie Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion Mol. Cancer Ther. 2009 8 2894 2902
35. J. Won M. Kim N. Kim J. H. Ahn W. G. Lee S. S. Kim K. Y. Chang Y. W. Yi T. K. Kim Small molecule-based reversible reprogramming of cellular lifespan Nat. Chem. Biol. 2006 2 369 374
36. M. D. Rainey M. E. Charlton R. V. Stanton M. B. Kastan Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation Cancer Res. 2008 68 7466 7474
37. L. I. Toledo M. Murga R. Zur R. Soria A. Rodriguez S. Martinez J. Oyarzabal J. Pastor J. R. Bischoff O. Fernandez-Capetillo A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations Nat. Struct. Mol. Biol. 2011 18 721 727
38. A. Peasland L. Z. Wang E. Rowling S. Kyle T. Chen A. Hopkins W. A. Cliby J. Sarkaria G. Beale R. J. Edmondson N. J. Curtin Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines Br. J. Cancer 2011 105 372 381
39. M. Hollstein D. Sidransky B. Vogelstein C. C. Harris p53 mutations in human cancers Science 1991 253 49 53
40. A. J. Levine J. Momand C. A. Finlay The p53 tumour suppressor gene Nature 1991 351 453 456
41. S. N. Powell J. S. DeFrank P. Connell M. Eogan F. Preffer D. Dombkowski W. Tang S. Friend Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay Cancer Res. 1995 55 1643 1648
42. Y. Luo S. K. Rockow-Magnone M. K. Joseph J. Bradner C. C. Butler S. K. Tahir E. K. Han S. C. Ng J. M. Severin E. J. Gubbins R. M. Reilly A. Rueter R. L. Simmer T. F. Holzman V. L. Giranda Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents Anticancer Res. 2001 21 23 28